HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tecle, T. Articles by Hartshorn, K. L. Search for Related Content PubMed PubMed Citation Articles by Tecle, T. Articles by Hartshorn, K. L.

Human Neutrophil Defensins Increase Neutrophil Uptake of Influenza A Virus and Bacteria and Modify Virus-Induced Respiratory Burst Responses

Tesfaldet Tecle^*, Mitchell R. White^*, Don Gantz, Erika C. Crouch and Kevan L. Hartshorn^1,*

^* Department of Medicine, Boston University School of Medicine and Department of Biophysics, Boston, MA 02118; and Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 
Human neutrophil peptides (HNPs) are released from granules of neutrophils in response to various activating stimuli and they participate in the killing of bacteria and the stimulation of various inflammatory responses. HNPs also inhibit infectivity of enveloped viruses, including influenza A virus (IAV). In this study, we demonstrate that HNPs increase the uptake of IAV and bacteria by neutrophils. The dimeric HNPs also induced aggregation of IAV and bacterial particles, which may, in part, explain their ability to increase uptake. HNPs did not increase neutrophil respiratory burst responses to IAV. We have recently demonstrated direct interactions of HNPs with surfactant protein D (SP-D), another important effector of innate immunity and antimicrobial host defense. Although HNPs did not alter SP-D-dependent uptake of IAV, they counteracted the ability of SP-D to increase IAV-induced neutrophil H₂O₂ generation. Our studies reveal previously unappreciated functional effects of HNPs, expand our understanding of the antiviral properties of HNPs, and suggest important interactions between collectins and HNPs in the host response to viruses and bacteria.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 
Influenza A virus (IAV)² infections are a major cause of morbidity and mortality, causing 40,000 deaths per year in the United States (1). Innate immune mechanisms provide important protection against IAV in the naive host. In this study, we evaluate three important innate defense mediators, neutrophils, human neutrophil peptides (HNP), and surfactant protein D (SP-D), with IAV. Neutrophils are recruited to the respiratory tract early in the course of IAV infection (2, 3, 4). Highly pathogenic IAV strains elicit more profound neutrophil influx (3, 5). Recent studies with the 1918 pandemic IAV strain demonstrate markedly increased neutrophil influx in the lungs of mice infected with this strain, as compared to the infection with other recent human strains. In this model, depletion of neutrophils before infection reduced survival. Hence, in this case, neutrophils clearly play a protective role. Other studies have shown both protective and adverse effects of neutrophil infiltration during IAV infection (4, 6).

Neutrophils bind to, and take up, IAV in the absence of Abs, and IAV stimulates various activation signals and H₂O₂ generation by neutrophils. In addition, various functional properties of neutrophils are impaired during IAV infection or after incubation with IAV in vitro. This dysfunction could contribute to bacterial superinfection, which is a major cause of morbidity and mortality during IAV epidemics (7, 8).

HNPs may contribute to host defenses against IAV. Defensins have antimicrobial activity against a variety of organisms, such as bacteria, fungi, and enveloped viruses, including IAV and HIV, among others (9, 10). In humans, -defensins are stored and released in large quantities, from neutrophil granules during infectious and inflammatory states (11, 12) and are referred to as HNP 1, 2, or 3. HNPs are basic peptides 29–30 aa in length. HNPs 1–3 differ by a single N-terminal amino acid. The peptides have a -sheet-rich fold and six disulfide-linked cysteines, resulting in a spatial segregation of charged and hydrophobic residues. It has been proposed that this amphiphilic structure could permit defensins to insert into the membranes of target organisms. In addition to their direct antimicrobial activities, defensins have a variety of other activities relevant to innate or adaptive immunity. Defensins have chemotactic activity for monocytes, T cells, and dendritic cells; stimulate IL-8 production by epithelial cells; bind to lipid bilayers; and contribute to respiratory epithelial cell activation, injury, or growth under some circumstances (13, 14, 15, 16, 17, 18, 19).

SP-D plays particularly important roles in restricting IAV replication and limiting the severity of inflammatory responses during the first several days of infection (3, 20, 21, 22, 23, 24, 25). SP-D directly inhibits the infectivity of IAV and also modulates the interaction of IAV with neutrophils. SP-D promotes the uptake of IAV by neutrophils, and can either increase or reduce respiratory burst responses of neutrophils upon exposure to IAV, depending on whether SP-D is first incubated with IAV or neutrophils (26). SP-D also protects neutrophils against IAV-induced neutrophil dysfunction (20, 21). We have recently shown that HNPs bind to SP-D and significantly modify its interactions with IAV (27). In this study, we show that HNPs promote IAV and bacterial uptake by neutrophils and modify neutrophil respiratory burst responses to IAV.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 
Buffers

Dulbecco’s PBS containing 0.9 mM calcium and 0.493 mM magnesium and PBS without calcium and magnesium were purchased from Invitrogen Life Technologies. PBS with added calcium and magnesium (pH 7.2) was used, unless otherwise indicated.

Virus and bacterial preparations

IAV was grown in the chorioallantoic fluid of 10-day-old chicken eggs and purified on a discontinuous sucrose gradient as previously described (28). The virus was dialyzed against PBS to remove sucrose, aliquoted, and stored at –80°C until needed. Philippines 82/H3N2 (Phil82) strain was provided by Dr. E. M. Anders (University of Melbourne, Melbourne, Australia). The A/PR/8/34/H1N1 (PR-8) strain was a gift from Dr. J. Abramson (Bowman Gray School of Medicine, Winston-Salem, NC). The hemagglutinin titer of each virus preparation was determined by titration of virus samples in PBS with thoroughly washed human type O, Rh^– RBC as described previously (28). After thawing, the viral stocks contained 5 x 10⁸ PFU/ml. Labeled Escherichia coli and Staphylococcus aureus were purchased from Molecular Probes.

Defensin and SP-D preparations

HNP1 and HNP2 were purchased from Bachem. HNP3, human defensin 5 (HD5), human -defensin (HBD) 1, and human -defensin 2 (HBD2) were purchased from the Peptide Institute. Recombinant human SP-D (RhSP-D) was produced in stably transfected Chinese hamster ovary-K1 cells as previously described (22). For these studies, the dodecameric fraction of RhSP-D was used. The SP-D and HNP preparations used in this study were tested for the degree of contamination with endotoxin using a quantitative endotoxin assay (Limulus amebocyte lysate; BioWhittaker). The levels of endotoxin in the HNP preparations were 15 and 25 pg/µg of protein, respectively, for HNP1 and HNP2. The levels of endotoxin in SP-D preparations were 2 pg/ml. Normal volunteer donor bronchoalveolar lavage fluid (BALF) was obtained under a protocol approved by the Boston University Medical Center Institutional Review Board.

Measurement of aggregation of viral and bacterial particles

Aggregation of IAV particles was assessed following the addition of various concentrations of collectins by monitoring changes in light transmission on a SLM/Aminco 8000C (SLM Instrument) spectrofluorometer as described elsewhere (29). The aggregation of viral particles is demonstrated by a decline in light transmission (i.e., increased turbidity). Bacterial aggregation was measured by a similar method, as previously described (30). However, in the case of bacteria, aggregation is indicated by increased light transmission through the suspension as the bacteria sediment. In addition, viral and bacterial aggregation were assessed by fluorescence microscopy as described previously (30).

To demonstrate aggregation by electron microscopy, Phil82 virus was preincubated with HNPs 1 or 2 (or control buffer) under the identical conditions used in the neutrophil uptake experiments (i.e., same concentrations of virus and HNP for the same time). These samples were then allowed to adhere to glow-discharged (31), carbon-coated copper grids for 30 min at room temperature, fixed with 2.5% glutaraldehyde for 5 min, and counterstained with 1% sodium phosphotungstate (pH 7.4) (32). Micrographs were recorded on Kodak SO163 film in a CM12 transmission electron microscope (Philips). Images were developed in D19, digitized on a CreoScitex EverSmart Supreme Scanner, and assembled in Adobe Photoshop.

Neutrophil preparation

Neutrophils from healthy volunteers were isolated to >95% purity by using dextran precipitation followed by Ficoll-Paque gradient separation for the removal of mononuclear cells and then hypotonic lysis to eliminate any contaminating erythrocytes, as previously described (28). Cell viability was determined to be >98% by trypan blue staining. The isolated neutrophils were resuspended at the appropriate concentrations in control buffer (PBS) and used within 2 h.

Measurement of IAV and bacterial uptake by neutrophils

During flow cytometry on neutrophils in suspension, FITC-labeled IAV (Phil82 strain) was prepared as described previously (29). Uptake of the virus by neutrophils was measured as previously described (23). In brief, IAV was preincubated with control buffer or various concentrations of collectins for 30 min at 37°C to test the effect of collectin on IAV binding, followed by incubation of aliquots of these samples with neutrophils for 30 min at 37°C. Trypan blue (0.2 mg/ml) was added to these samples to quench extracellular fluorescence. After washing, the neutrophils were fixed with paraformaldehyde, and neutrophil-associated fluorescence was measured using flow cytometry. The mean neutrophil fluorescence (>1000 cells counted per sample) was measured.

Measurement of neutrophil H₂O₂ production

H₂O₂ production was measured by assessing the reduction in scopoletin fluorescence as previously described (33).

Statistics

Statistical comparisons were made using a Student’s paired, two-tailed t test or ANOVA with post hoc test (Tukey’s).

	Results

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 
HNP1 and HNP2 and HD5 increase neutrophil uptake of IAV

SP-D increases the neutrophil uptake of IAV (20) and bacteria (30). Initially, we planned to determine whether this activity of SP-D is altered by HNP. Unexpectedly, we found that HNP1 and HNP2 alone strongly increase the neutrophil uptake of IAV (Fig. 1A). HNP1 and HNP2 caused very similar increases in the uptake of IAV, with peak effects at 20–40 µg/ml. We tested the effect of preincubating neutrophils with HNP1 and HNP2 on the subsequent uptake of IAV (Fig. 1B). Neutrophils were preincubated with 50 µg/ml HNP1 or HNP2 for 30 min at 37°C, followed by the washing and addition of FITC-labeled IAV. HNP1 and HNP2 again significantly increased viral uptake (Fig. 1, lower panel); however, the degree of increase in uptake was less pronounced in these experiments than when the virus was preincubated with HNPs. We also found that the preincubation of IAV with HNPs increases uptake of IAV by plastic-adherent neutrophils (Fig. 2).

View larger version (17K): [in this window] [in a new window]   FIGURE 1. HNPs increase the neutrophil uptake of IAV. Neutrophil uptake of FITC-labeled IAV was measured by flow cytometry. A, IAV was preincubated with the indicated concentrations of HNP1 or HNP2, and aliquots of these samples were added to neutrophils. Both HNPs caused significant increases in the uptake of IAV by neutrophils (p < 0.005 for 20 and 40 µg/ml HNPs compared with control; n = 6 experiments using separate blood donors). B, Neutrophils were preincubated with HNPs, followed by washing and addition of IAV. Using this method, HNPs still significantly increased the uptake of IAV (p values as indicated); however, the increase in uptake was significantly less than when IAV was preincubated with the HNPs (p < 0.05 by ANOVA). C, The ability of -defensins 1 and 2, HNP3, and HD5 were tested in a similar manner as in A (i.e., preincubation of defensins with the virus before adding to neutrophils). As shown, HD5 increased viral uptake, while BD1 and HNP3 did not, and BD2 caused a slightly increased uptake at the highest concentration tested (p values are shown).

View larger version (76K): [in this window] [in a new window]   FIGURE 2. HNPs increase the uptake of IAV by adherent neutrophils. Neutrophils were allowed to adhere to plastic slides followed by washing and incubation with either IAV alone or IAV that had been preincubated with either HNP1 or HNP2. Left, Fluorescent microscopy; right, same fields in phase-contrast microscopy. Increased neutrophil-associated fluorescence was clearly evident in samples treated with HNPs. Results are representative of four similar experiments.

To determine whether other defensins have a similar ability to increase the neutrophil uptake of IAV, we preincubated Phil82 IAV with HNP3, HD5, HBD1, or HBD2 and tested uptake by flow cytometry (Fig. 1C). HD5 is an -defensin produced by Paneth cells in the gastrointestinal mucosa and by vaginal epithelial cells. HNP3, like HNP1 and HNP2, is produced by neutrophils and other myeloid cells. HBD1 and HBD2 are produced by various epithelial cells. HD5 strongly increased IAV uptake by neutrophils, but HNP3 and HBD1 did not. HB2 slightly (but statistically significantly) increased viral uptake at 40 µg/ml.

HNPs promote clearance of IAV by neutrophils

Live, unlabeled IAV was incubated in vitro with HNPs or neutrophils alone or with combinations of HNPs with neutrophils. Following incubation, the samples were subjected to low-speed centrifugation to determine residual virus present in cell-free supernatants. Neutrophils alone did not cause a significant decrease in IAV in the supernatant in this assay as measured by hemagglutination titers (Fig. 3). HNPs alone caused a decrease in virus in supernatant; however, the decrease in virus was significantly greater when HNPs and neutrophils were combined. This supports the notion that HNPs promote neutrophil-mediated clearance of IAV. It is of interest as well that HNPs alone caused a drop in virus in the supernatant, presumably due to viral aggregation leading to precipitation of the virus at low-speed centrifugation.

View larger version (17K): [in this window] [in a new window]   FIGURE 3. HNPs promote the neutrophil-mediated clearance of IAV from culture supernatant. IAV was incubated with HNPs or neutrophils alone or the combination of HNPs and neutrophils, followed by low-speed centrifugation and determination of viral titers in cell-free supernatant by hemagglutinin assay. Results are mean ± SEM of five experiments. HNP1 alone significantly reduced viral titers in the supernatant (p < 0.001 vs control); however, HNP1 and neutrophils together caused a significantly greater reduction in viral titers (p < 0.01 for HNP1 alone vs HNP1 + neutrophils).

Our previous studies suggest that the ability of SP-D to increase neutrophil binding and uptake of IAV correlates with viral aggregation by SP-D. HNPs caused aggregation of two different strains of IAV (Phil82 and PR-8) as assessed by measuring light transmission through stirred suspensions of IAV (Fig. 4, upper panel) or by fluorescent microscopy using a rhodamine-labeled Phil82 strain of IAV (Fig. 4, lower panel). Fig. 5 shows the appearance of viral aggregates induced by HNPs on electron microscopy.

View larger version (40K): [in this window] [in a new window]   FIGURE 4. HNPs cause aggregation of IAV particles. Aggregation of viral particles (Phil82 or PR-8 strain) was tested using a sensitive assay of light transmission through stirred viral suspensions (upper, n = 5 for Phil82; n = 2 for PR-8) and by examination under fluorescent microscopy (lower, rhodamine-labeled Phil82 IAV; representative of four experiments).

View larger version (74K): [in this window] [in a new window]   FIGURE 5. Viral aggregation by HNPs as demonstrated by electron microscopy. Representative electron micrographs from three separate experiments are shown. Exposures were taken at x8,000 and x60,000 of control virus (Phil82 strain) or virus that was pretreated with 40 µg/ml HNP1 or HNP2 in the identical manner as in Fig. 1.

HNPs have previously been reported to inhibit neutrophil respiratory burst responses (34). IAV alone triggers modest H₂O₂ production by neutrophils, an effect that is significantly increased by preincubation of the virus with certain concentrations of RhSP-D (Ref. 20 and Fig. 6). Preincubation of IAV with HNPs did not increase IAV-induced H₂O₂ generation. However, when IAV was preincubated with both RhSP-D and HNP1 or HNP2, the enhancing effect of RhSP-D was reduced (Fig. 6). HNP1 or HNP2 did not significantly alter H₂O₂ production induced by fMLP in parallel experiments (n = 4; data not shown).

View larger version (15K): [in this window] [in a new window]   FIGURE 6. HNPs do not increase neutrophil H2O2 production in response to IAV and counteract the increase caused by SP-D. IAV was preincubated with either SP-D, HNP1, or HNP2 alone or combinations of SP-D with HNPs. SP-D strongly increased IAV-stimulated H2O2 production as previously reported. However, this effect was significantly reduced by HNPs (p values shown). Results are mean ± SEM of four or five experiments.

To determine whether the HNPs have a more general effect on neutrophil phagocytosis, we tested the effect of preincubation S. aureus or E. coli with HNPs on uptake of these bacteria. As shown in Fig. 7, HNP1 and HNP2 increased uptake of both of these bacteria by neutrophils as assessed by flow cytometry. Fig. 8 shows representative fluorescent micrographs of adherent neutrophils in which HNP1 and HNP2 increased the neutrophil uptake of E. coli and S. aureus. Adherent neutrophils appeared to phagocytose very few bacteria in the absence of HNPs, and HNPs caused clear-cut increases in cell-associated bacteria as shown. RhSP-D increased the neutrophil uptake of E. coli as previously reported (30); however, SP-D did not as clearly increase the uptake of S. aureus. Fig. 9 demonstrates that HNPs induced the aggregation of E. coli and S. aureus.

View larger version (17K): [in this window] [in a new window]   FIGURE 7. HNPs increase the uptake of S. aureus and E. coli by suspended neutrophils. Neutrophils in suspension were incubated with fluorescently labeled S. aureus or E. coli for 45 min at 37°C, and cell-associated fluorescence was detected using flow cytometry. When the bacteria were preincubated with HNP1 or HNP2 (µg/ml) for 30 min before incubation with neutrophils, uptake of the bacteria was significantly increased (p values given).

View larger version (58K): [in this window] [in a new window]   FIGURE 8. HNPs increase the uptake of bacteria by adherent neutrophils. Neutrophils were allowed to adhere to plastic coverslips, and the cells were then exposed to fluorescently labeled E. coli and S. aureus as in Fig. 6. The bacteria were preincubated with either control buffer alone or with either HNP1 or HNP2 as shown. Results are from one experiment representative of four experiments done with separate blood donors.

View larger version (44K): [in this window] [in a new window]   FIGURE 9. HNPs induce aggregation of bacteria. Fluorescently labeled E. coli and S. aureus were treated with control buffer or HNP1 or HNP2 and slides were prepared and examined under fluorescent microscopy. Results are representative of three or more experiments.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

Preincubation of neutrophils with HNPs caused a much more modest (although still statistically significant) increase in viral uptake. -Defensins appear to have lower activity than -defensins, because HBD1 had no activity, and HBD2 had modest activity compared with HNP1 and HNP2 or HD5. Fleischman et al. (35) reported that MCP-1 and MCP-2 increase the uptake of bacteria and Candida by rabbit alveolar macrophages, perhaps representing a similar phenomenon to what we have reported in this study. Further studies involving additional cationic peptides and phagocytic cell types will, therefore, be of interest.

It is notable that HNP3 did not increase viral uptake, given its close relationship to HNP1 and HNP2. HNP1 and HNP3 differ from HNP2 only in having, respectively, an additional alanine or aspartic acid at the N terminus. However, there is evidence indicating that the N-terminal aspartic acid impacts the function of the molecule considerably. HNP3 exists as a dimer with an amphiphilic structure, and the N-terminal aspartic acid is located on the charged surface of the molecule. HNP3 has greatly reduced antibacterial and anti-candidal activity compared to HNP1 and HNP2 (36). Our results suggest that N-terminal amino acids on HNPs can modulate prophagocytic activity as well.

The mechanisms through which HNPs promote phagocytosis require more study; however, we demonstrate one possible mechanism: HNP-induced aggregation of IAV and bacteria. A similar effect appears to contribute to enhanced viral uptake caused by SP-D (21, 30, 37, 38). The need for the preincubation of IAV with HNPs to obtain optimal enhancement of uptake is consistent with a role for viral aggregation; however, a contribution of direct effects of HNPs on neutrophils is also possible.

The finding that HNPs can induce viral and bacterial aggregation is also of interest, because it implies that HNPs can cross-link viral or bacterial particles to each other. It is likely that the dimerization of higher levels of oligomerization (39) of the HNPs are involved in this activity (and, by extension, in increased neutrophil uptake). It is unlikely that the lectin activity of HNPs (40) contributes to their ability to aggregate IAV, because aggregation of the PR-8 strain was greater than aggregation of the Phil82 strain. The PR-8 strain is a mouse-adapted human strain that has greatly diminished glycosylation on its envelope proteins compared with the Phil82 strain (41, 42).

The ability of HNPs to promote neutrophil-mediated clearance of IAV from culture supernatants was confirmed by an independent technique involving live, unlabeled virus. It is likely that HNPs participate in host defense against IAV during the early phase of infection that is characterized by an influx of neutrophils into the infected respiratory tract (2, 5). It is intriguing to speculate that neutrophils themselves can promote phagocytosis through the release of HNPs during viral or bacterial infection.

We report that HNPs reduced neutrophil H₂O₂ production in response to SP-D-treated IAV. Under the conditions of our assay, this effect appeared to be specific to IAV-induced responses, since responses to fMLP were not reduced. The finding that HNPs increase IAV uptake without increasing virus-induced respiratory burst responses suggests that HNPs may promote viral uptake without exacerbating oxidant injury, which contributes to the pathogenesis of severe IAV infection in animal models (43).

SP-D has complex effects on neutrophil oxidant responses to IAV. In the absence of SP-D, IAV triggers an atypical activation response characterized by H₂O₂ release in the absence of a superoxide generation (33, 44, 45). IAV also depresses superoxide responses of neutrophils to a variety of other stimuli (46). However, preincubation of IAV with SP-D increases H₂O₂ production (20). In contrast, if neutrophils are first preincubated with SP-D, a reduced H₂O₂ response of the cells to IAV is observed (26). Of interest, it has been reported that HNPs suppress the oxidative metabolism of neutrophils and reduce their ability to kill S. aureus (34). We have found that HNPs bind to SP-D, which could account in part for the ability of HNPs to counteract the SP-D-induced increase in respiratory burst responses to IAV (27). We have found that several other components of respiratory fluids including surfactant protein A, mucins, and scavenger receptor-rich gp340 counteract the ability of SP-D to increase IAV-induced H₂O₂ responses and have shown that BALF per se does not increase H₂O₂ responses to IAV (26).

Our findings reveal a previously unappreciated feature of the functional activity of HNPs and suggest that HNPs modulate host defense in IAV or bacterial infection through direct antiviral and antibacterial effects and through inducing viral and bacterial aggregation with altered interactions of the pathogens with neutrophils. Future studies will address how HNPs modulate viral or bacterial trafficking within neutrophils or macrophages.

	Disclosures

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 
The authors have no financial conflict of interest.

	Footnotes

 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ Address correspondence and reprint requests to Dr. Kevan L. Hartshorn, Boston University School of Medicine, Evans Biomedical Research Center 414, 650 Albany Street, Boston, MA 02118. E-mail address: khartsho{at}bu.edu

² Abbreviations used in this paper: IAV, influenza A virus; HNP, human neutrophil peptide; SP-D, surfactant protein D; HD5, human defensin 5; HBD, human -defensin; RhSP-D, recombinant human SP-D; BALF, bronchoalveolar lavage fluid.

Received for publication June 20, 2006. Accepted for publication April 11, 2007.

	References

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 

1. Morens, D.. 2003. Influenza-related mortality: considerations for practice and public health. J. Am. Med. Assoc. 289: 227-229. [Free Full Text]
2. Sweet, C., H. Smith. 1980. Pathogenicity of influenza virus. Microbiol. Rev. 44: 303-330. [Free Full Text]
3. LeVine, A., J. Whitsett, K. Hartshorn, T. Korfhagen. 2001. Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J. Immunol. 167: 5868-5873. [Abstract/Free Full Text]
4. Sakai, S., H. Kawamata, N. Mantani, T. Kogure, Y. Shimada, K. Terasawa, T. Sakai, N. Imanishi, H. Ochiai. 2000. Therapeutic effect of anti-macrophage inflammatory protein 2 antibody in influenza virus-induced pneumonia in mice. J. Virol. 74: 2472-2476. [Abstract/Free Full Text]
5. Tumpey, T. M., A. Garcia-Sastre, J. K. Taubenberger, P. Palese, D. E. Swayne, M. J. Pantin-Jackwood, S. Schultz-Cherry, A. Solorzano, N. Van Rooijen, J. M. Katz, C. F. Basler. 2005. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J. Virol. 79: 14933-14944. [Abstract/Free Full Text]
6. Fujisawa, H., S. Tsuru, M. Taniguchi, Y. Zinnaka, K. Nomoto. 1987. Protective mechanisms against pulmonary infection with influenza virus: I. Relative contribution of polymorphonuclear leukocytes and of alveolar macrophages to protection during the early phase of intranasal infection. J. Gen. Virol. 68: 425-432. [Abstract/Free Full Text]
7. Hartshorn, K.. 1996. Etiology of bacterial superinfections complicating influenza viral infection. L. Brown, and A. Hampson, and R. Webster, eds. Options for the Control of Influenza 499-508. Elsevier Science, Amsterdam.
8. Engelich, G., D. Wright, K. Hartshorn. 2001. Acquired disorders of phagocyte function complicating medical and surgical illnesses. Clin. Infect. Dis. 33: 2040-2048. [Medline]
9. Chang, T. L., J. Vargas, Jr, A. DelPortillo, M. E. Klotman. 2005. Dual role of -defensin-1 in anti-HIV-1 innate immunity. J. Clin. Invest. 115: 765-773. [Medline]
10. Daher, K., M. Selsted, R. Lehrer. 1986. Direct inactivation of viruses by human granulocyte defensins. J. Virol. 60: 1068-1074. [Abstract/Free Full Text]
11. Ashitani, J., H. Mukae, T. Hiratsuka, M. Nakazato, K. Kumamoto, S. Matsukura. 2002. Elevated levels of -defensins in plasma and BAL fluid of patients with active pulmonary tuberculosis. Chest 121: 519-526. [Medline]
12. Spencer, L. T., G. Paone, P. M. Krein, F. N. Rouhani, J. Rivera-Nieves, M. L. Brantly. 2004. Role of human neutrophil peptides in lung inflammation associated with ₁-antitrypsin deficiency. Am. J. Physiol. 286: L514-L520.
13. Lichtenstein, A. K., T. Ganz, T. M. Nguyen, M. E. Selsted, R. I. Lehrer. 1988. Mechanism of target cytolysis by peptide defensins: target cell metabolic activities, possibly involving endocytosis, are crucial for expression of cytotoxicity. J. Immunol. 140: 2686-2694. [Abstract]
14. Kagan, B. L., M. E. Selsted, T. Ganz, R. I. Lehrer. 1990. Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc. Natl. Acad. Sci. USA 87: 210-214. [Abstract/Free Full Text]
15. Okrent, D. G., A. K. Lichtenstein, T. Ganz. 1990. Direct cytotoxicity of polymorphonuclear leukocyte granule proteins to human lung-derived cells and endothelial cells. Am. Rev. Respir. Dis. 141: 179-185. [Medline]
16. Chertov, O., D. F. Michiel, L. Xu, J. M. Wang, K. Tani, W. J. Murphy, D. L. Longo, D. D. Taub, J. J. Oppenheim. 1996. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleuking-8-stimulated neutrophils. J. Biol. Chem. 271: 2935-2940. [Abstract/Free Full Text]
17. van Wetering, S., S. P. Mannesse-Lazeroms, M. A. Van Sterkenburg, M. R. Daha, J. H. Dijkman, P. S. Hiemstra. 1997. Effect of defensins on interleukin-8 synthesis in airway epithelial cells. Am. J. Physiol. 272: L888-L896. [Medline]
18. van Wetering, S., A. C. van der Linden, M. A. J. A. van Sterkenburg, W. I. de Boer, A. L. Kuijpers, J. Schalkwijk, P. S. Hiemstra. 2000. Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins. Am. J. Physiol. 278: L51-L58.
19. Aarbiou, J., M. Ertmann, S. van Wetering, P. van Noort, D. Rook, K. F. Rabe, S. V. Litvinov, J. H. van Krieken, W. I. de Boer, P. S. Hiemstra. 2002. Human neutrophil defensins induce lung epithelial cell proliferation in vitro. J. Leukocyte Biol. 72: 167-174. [Abstract/Free Full Text]
20. Hartshorn, K. L., E. C. Crouch, M. R. White, P. Eggleton, A. I. Tauber, D. Chang, K. Sastry. 1994. Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J. Clin. Invest. 94: 311-319. [Medline]
21. Hartshorn, K., K. Reid, M. White, S. Morris, J. Jensenius, E. Crouch. 1996. Neutrophil deactivation by influenza A viruses: mechanisms of protection after viral opsonization with collectins and hemagglutination-inhibiting antibodies. Blood 87: 3450-3461.
22. Hartshorn, K., D. Chang, K. Rust, M. White, J. Heuser, E. Crouch. 1996. Interactions of recombinant human pulmonary surfactant protein D and SPD multimers with influenza A. Am. J. Physiol. 271: L753-L762. [Medline]
23. Hartshorn, K., M. White, V. Shepherd, K. Reid, J. Jensenius, E. Crouch. 1997. Mechanisms of anti-influenza activity of pulmonary surfactant proteins A and D: comparison with other collectins. Am. J. Physiol. 273: L1156-L1166. [Medline]
24. Hartshorn, K., M. White, D. Voelker, J. Coburn, K. Zaner, E. Crouch. 2000. Mechanism of binding of surfactant surfactant protein D to influenza A viruses: importance of binding to hemagglutinin to antiviral activity. Biochem. J. 351: 449-458. [Medline]
25. LeVine, A., K. Hartshorn, J. Elliot, J. Whitsett, T. Korfhagen. 2001. Surfactant protein A modulates both innate and adaptive defense responses to pulmonary influenza A virus infection. Am. J. Physiol. 282: L563-L572.
26. White, M. R., E. Crouch, J. Vesona, P. J. Tacken, J. J. Batenburg, R. Leth-Larsen, U. Holmskov, K. L. Hartshorn. 2005. Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus. Am. J. Physiol. 289: L606-L616.
27. Hartshorn, K. L., M. R. White, T. Tecle, U. Holmskov, E. C. Crouch. 2006. Innate defense against influenza A virus: activity of human neutrophil defensins and interactions of defensins with surfactant protein D. J. Immunol. 176: 6962-6972. [Abstract/Free Full Text]
28. Hartshorn, K. L., M. Collamer, M. Auerbach, J. B. Myers, N. Pavlotsky, A. I. Tauber. 1988. Effects of influenza A virus on human neutrophil calcium metabolism. J. Immunol. 141: 1295-1301. [Abstract]
29. Hartshorn, K. L., K. Sastry, D. Brown, M. R. White, T. B. Okarma, Y. Lee, A. I. Tauber. 1993. Conglutinin acts as an opsonin for influenza A viruses. J. Immunol. 151: 1-9. [Abstract]
30. Hartshorn, K., E. Crouch, M. White, M. Colamussi, A. Kakkanatt, B. Tauber, V. Shepherd, K. Sastry. 1998. Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria. Am. J. Physiol. 274: L958-L969. [Medline]
31. Dubochet, J., M. Groom, S. Mueller-Neuteboom. 1982. The mounting of macromolecules for electron microscopy with particular reference to surface phenomena and the treatment of support films with glow discharge. Adv. Opt. Electron Microsc. 8: 107-135.
32. Harris, J., R. Horne. 1991. Negative staining. J. Harris, Jr, ed. Electron Microscopy in Biology 203-228. IRL, Oxford U.K.
33. Hartshorn, K. L., M. Collamer, M. R. White, J. H. Schwartz, A. I. Tauber. 1990. Characterization of influenza A virus activation of the human neutrophil. Blood 75: 218-226. [Abstract/Free Full Text]
34. Kaplan, S. S., R. P. Heine, R. L. Simmons. 1999. Defensins impair phagocytic killing by neutrophils in biomaterial-related infection. Infect. Immun. 67: 1640-1645. [Abstract/Free Full Text]
35. Fleischmann, J., M. E. Selsted, R. I. Lehrer. 1985. Opsonic activity of MCP-1 and MCP-2, cationic peptides from rabbit alveolar macrophages. Diagn. Microbiol. Infect. Dis. 3: 233-242. [Medline]
36. Raj, P. A., K. J. Antonyraj, T. Karunakaran. 2000. Large-scale synthesis and functional elements for the antimicrobial activity of defensins. Biochem. J. 347: 633-641. [Medline]
37. White, M., E. Crouch, D. Chang, K. Sastry, N. Guo, G. Engelich, K. Takahashi, R. Ezekowitz, K. Hartshorn. 2000. Enhanced antiviral and opsonic activity of a human mannose binding lectin and surfactant protein D fusion protein. J. Immunol. 165: 2108-2155. [Abstract/Free Full Text]
38. Brown-Augsburger, P., K. Hartshorn, D. Chang, K. Rust, C. Fliszar, H. Welgus, E. Crouch. 1996. Site directed mutagenesis of Cys15 and Cys20 of pulmonary surfactant protein D: expression of a trimeric protein with altered anti-viral properties. J. Biol. Chem. 271: 13724-13730. [Abstract/Free Full Text]
39. Hill, C., J. Yee, M. Selsted, D. Eisenberg. 1991. Crystal structure of defensin HNP-3, and amphiphilic dimer: mechanisms of membrane permeabilization. Science 251: 1481-1485. [Abstract/Free Full Text]
40. Leikina, E., H. Delanoe-Ayari, K. Melikov, M. S. Cho, A. Chen, A. J. Waring, W. Wang, Y. Xie, J. A. Loo, R. I. Lehrer, L. V. Chernomordik. 2005. Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat. Immunol. 6: 995-1001. [Medline]
41. Caton, A., G. Brownlee, J. Yewdell, W. Gerhard. 1982. The antigenic structure of influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31: 417-427. [Medline]
42. van Eijk, M., M. R. White, J. J. Batenburg, A. B. Vaandrager, L. M. van Golde, H. P. Haagsman, K. L. Hartshorn. 2004. Interactions of influenza A virus with sialic acids present on porcine surfactant protein D. Am. J. Respir. Cell Mol. Biol. 30: 871-879. [Abstract/Free Full Text]
43. Akaike, T., Y. Noguchi, S. Ijiri, K. Setoguchi, M. Suga, Y. Zheng, B. Dietzschold, H. Maeda. 1996. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. USA 93: 2448-2453. [Abstract/Free Full Text]
44. Kazhdan, M., M. R. White, A. I. Tauber, K. L. Hartshorn. 1994. Human neutrophil respiratory burst response to influenza A virus occurs at an intracellular location. J. Leukocyte Biol. 56: 59-64. [Abstract]
45. Hartshorn, K. L., D. E. Daigneault, M. R. White, A. I. Tauber. 1992. Anomalous features of human neutrophil activation by influenza A virus are shared by related viruses and sialic acid-binding lectins. J. Leukocyte Biol. 51: 230-236. [Abstract]
46. Hartshorn, K. L., L. S. Liou, M. R. White, M. M. Kazhdan, J. L. Tauber. 1995. Neutrophil deactivation by influenza A virus: role of hemagglutinin binding to specific sialic acid-bearing cellular proteins. J. Immunol. 154: 3952-3960. [Abstract]

This article has been cited by other articles:

				M. Doss, M. R. White, T. Tecle, D. Gantz, E. C. Crouch, G. Jung, P. Ruchala, A. J. Waring, R. I. Lehrer, and K. L. Hartshorn Interactions of {alpha}-, {beta}-, and {theta}-Defensins with Influenza A Virus and Surfactant Protein D J. Immunol., June 15, 2009; 182(12): 7878 - 7887. [Abstract] [Full Text] [PDF]

				G. Diamond, N. Beckloff, and L.K. Ryan Host Defense Peptides in the Oral Cavity and the Lung: Similarities and Differences Journal of Dental Research, October 1, 2008; 87(10): 915 - 927. [Abstract] [Full Text] [PDF]

				M. R. White, T. Tecle, E. C. Crouch, and K. L. Hartshorn Impact of neutrophils on antiviral activity of human bronchoalveolar lavage fluid Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1293 - L1299. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tecle, T. Articles by Hartshorn, K. L. Search for Related Content PubMed PubMed Citation Articles by Tecle, T. Articles by Hartshorn, K. L.